Effects of Milk-based Drinks on Gut Microbiome, Sleep and Cardiometabolic Markers

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-31

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the effects of kefir on gastrointestinal health, sleep quality, and biochemical parameters in adults who have sleep problems. Further measurements of cognitive function, arterial stiffness and blood pressure will also be assessed.

The following questions will be addressed during the study:

1. What effect does repeated ingestion of kefir have on the gut microbiome and can this positively influence sleep performance (quality and duration) in adults with sleep problems?
2. Does repeated ingestion of kefir impact LDL, triacyglycerols and non-HDLc in adults with sleep problems?
3. What effect does repeated ingestion of kefir have on cognitive function and mood?
4. What effect does repeated ingestion of kefir have on vascular function, inflammation and markers of immunity in adults with sleep problems?

In a randomised, crossover design study, participants will consume 250 ml of kefir (original flavour) or milk for 4 weeks with a 4-week washout.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Kefir Consumption on Various Parameters in Adults Subjects

NCT05715008

Oxidative Stress

UNKNOWN NA

Kefir and Metabolic Syndrome

NCT03649828

Metabolic Syndrome Cardiovascular Diseases Hypertension

COMPLETED NA

Improving Health Outcomes With Kefir

NCT06695221

Systemic Inflammatory Response Diabetes Mellitus, Type 2 Cardiovascular Diseases

RECRUITING NA

Kefir and Metabolic Syndrome

NCT03966846

Metabolic Syndrome Obesity Hypertension +2 more

COMPLETED NA

Replacement of Saturated Fat in Dairy on Total Cholesterol

NCT02089035

Hypercholesterolemia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The gut microbiome is recognized as a key regulator of host health, influencing various physiological processes. Dysbiosis of the gut microbiome has been implicated in a range of adverse health outcomes, including disruptions in sleep architecture and impairments in cardiometabolic function. There is growing interest in identifying dietary interventions that can modulate gut microbiota composition and functionality. In particular, the consumption of fermented foods, such as kefir, has emerged as a potential strategy for promoting microbial homeostasis and improving health outcomes

This study conforms to a randomised, double-blind 2-arm crossover design. Participants will consume either Kefir (original flavour) or milk. Each arm will involve daily consumption of the drink for 4-weeks with a 4 week washout before crossing over to the opposite condition. Drinks will be administered in a counterbalanced order to minimise potential order effects.

The primary outcome of this study is a 5% change in LDL based on a previous study (Bellikci-Koyu et al., 2022).

Assuming type I error probability α = 0.05 and power of 80%, and effect size of 0.2 G\*power calculated that 32 participants would need to be recruited.

To account for potential drop out and balanced randomization, we will aim to recruit 40 participants.

Participants will be recruited through the use of posters around Sheffield Hallam University and the University of Leeds, through emails to staff and students, and contacts at surrounding universities. Potentially eligible participants will be identified through the use of a recruitment questionnaire before being invited to a screening visit for full consideration for the study. All participants will provide written informed consent before participating.

A linear mixed model analysis will be used to assess the effect of kefir on outcome parameters.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Cardiovascular Diseases Gut Microbiome Cognitive Function and Mood LDL Cholesterol

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

This trial conforms to a randomised, double-blind, 2 arm crossover. Participants will consume the active drink or a control drink for 4 weeks before crossing over to the opposite condition after a 4-week washout. Order of drink allocation will be counterbalanced.

Primary Study Purpose

OTHER

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Original Kefir

250ml of original kefir

Group Type ACTIVE_COMPARATOR

Original flavour kefir

Intervention Type DIETARY_SUPPLEMENT

Participants will consume 250ml of original flavour kefir daily for 4 weeks. According to the manufacturer, "packed with billions of live cultures to support Gut health".

Milk

250 ml of milk

Group Type SHAM_COMPARATOR

Milk

Intervention Type OTHER

Participants will consume 250 ml milk daily for 4 weeks. This milk will not contain any live cultures.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Original flavour kefir

Participants will consume 250ml of original flavour kefir daily for 4 weeks. According to the manufacturer, "packed with billions of live cultures to support Gut health".

Intervention Type DIETARY_SUPPLEMENT

Milk

Participants will consume 250 ml milk daily for 4 weeks. This milk will not contain any live cultures.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 40-70 years old
* Suffer with poor sleep (measured using the PIttsburg Sleep Quality Index with a score \> 5)
* BMI in range of 25-35 kg/m2
* Willingness to consume each study drink daily for 4 weeks and attend the laboratory on 4 separate occasions
* For women: Medication in the form of contraception or HRT providing these have not been modified 3 months prior to the first study day

Exclusion Criteria

* Intolerance or allergy to milk-based products
* Pregnancy/breastfeeding
* Insufficient English language skills to complete all study questionnaires and perform the cognitive tests
* Gastrointestinal disorders
* Inability to attend the laboratory due to travel/mobility difficulties

Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes